Susan Lorencz
Nurse Practitioner · Morehead City, NCNPI 1336255819
Payments from drug & device makers
Across 289 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$795
- AbbVie$640
- Takeda Pharmaceuticals U.S.A., Inc.$474
- Lilly USA, LLC$435
- Exeltis, USA Inc.$239
- Astellas Pharma US Inc$207
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,336100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 63 | $795 |
| AbbVie | 41 | $640 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $474 |
| Lilly USA, LLC | 33 | $435 |
| Exeltis, USA Inc. | 12 | $239 |
| Astellas Pharma US Inc | 12 | $207 |
| Axsome Therapeutics, Inc. | 12 | $194 |
| Radius Health, Inc. | 9 | $159 |
| Organon | 9 | $140 |
| Biohaven Pharmaceuticals, Inc. | 8 | $134 |
| Bayer | 8 | $130 |
| Idorsia Pharmaceuticals US Inc | 5 | $76 |
| Vivus LLC | 5 | $75 |
| Pfizer | 5 | $73 |
| Mayne Pharma Commercial LLC | 3 | $63 |
| Avion Pharmaceuticals | 3 | $52 |
| Exact Sciences | 3 | $50 |
| Myriad Women's Health, Inc. | 1 | $49 |
| Lundbeck LLC | 2 | $44 |
| Amgen | 3 | $43 |
| Abbott | 2 | $40 |
| Hologic Sales And Service, LLC | 2 | $32 |
| Evofem Biosciences, Inc. | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Neos Therapeutics, LP | 2 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $12 |
How this compares
$4,345 in reported general payments places this provider in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 13 | $13,461 |
| Estradiol | 36 | $2,085 |
| Clobetasol Propionate | 15 | $1,498 |
| ValacyclovirValacyclovir Hcl | 18 | $648 |
| Rosuvastatin Calcium | 37 | $461 |
| Bupropion XlBupropion Hcl | 11 | $227 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $146 |
| Fluoxetine Hcl | 15 | $117 |
| Amlodipine Besylate | 16 | $95 |
| Zolpidem Tartrate | 16 | $67 |
| Alprazolam | 17 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $435 | $13,46113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Morehead City
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
- Jamie DinerDurham$170K
- Ayeshia WrightMocksville$145K
- Deborah AllenDurham$112K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.